This summary is generated by an algorithm. If you find any mistakes, let us know.

Health Care Medical North America Personal Health

Meru Health secures $38M in equity and debt for ‘holistic’ online mental health platform

– Meru Health is a startup that aims to solve a number of the challenges associated with getting access to quality mental health care.
– The company has raised $38m in Series B funding.
Industry Ventures led the $30m equity part.
– Early backers Bold Capital Partners, Foundry Group, Freestyle VC, FMZ Ventures and Leksell Social Ventures also participated in the equity financing, while J.P. Morgan funded the debt portion of the round.

Source
Biotechnology Health Care Medical North America Pharmaceutical

Elligo Health Research Inks $135M Series E

– Elligo Health Research, a healthcare-enabling research organization powered by the novel IntElligo technology, announced a $135m Series E financing round.
Morgan Stanley Expansion Capital and Ally Bridge Group participated in the financing round.
– The round was also participated by Norwest Venture Partners and all major existing investors, including Cerner, Hatteras Venture Partners, Noro-Moseley Partners, Piper Sandler Merchant Banking, Shumway Capital, and Syneos Health.
– This financing allows Elligo to invest further in its technology platform and leverage data in new ways to address current challenges in the clinical trial industry.

Source
Biotechnology Health Care Hospital Medical North America

Fauna Bio Raises $9M in Seed Funding

– Fauna Bio is an Emeryville, California-based biotechnology company leveraging animal genomics to improve human health.
– The company raised $9m in Seed funding.
– The round was led by LifeForce Capital with participation from True Ventures, Boom Capital, Pacific 8 Ventures, BioMed Ventures, Vibe Capital and Arcadia Science.
– The new investment will be used to expand its drug discovery platform Convergence while accelerating the discovery of new therapeutic targets for human diseases across a broad range of indications.

Source
Consumer Reviews Health Insurance Information Technology Medical North America Software

Chapter Raises $17M in Series A Funding

– Chapter is a New York-based Medicare Advisor.
– The company raised $17M in Series A funding.
– The round was led by Narya Capital with participation from Susa Ventures, Maverick Ventures, XYZ Venture Capital, Core Innovation Capital and Health2047 Capital Partners.
– The new investment will be used to accelerate the company’s product development efforts, expand its team of engineers and licensed advisors, and further invest in supporting its members.

Source
Artificial Intelligence Health Care Information Technology Medical North America

Alpha Medical Raises $24M in Series B Funding

– Alpha Medical is a women’s virtual primary care company.
– Company raised $24m in Series B funding.
– The round was led by SpringRock Ventures, Margo Georgiadis, Outcomes Collective Growth Capital, FMZ Ventures, Samsung Next, Chamaeleon, AV8 Ventures, and GSR Ventures.
– The new investment will be used to expand operations and business reach.

Source
Health Care Information Technology Medical North America

Centivo raises $51 million as more employers seek affordable, quality healthcare for their employees

– Centivo, a new health plan for self-funded employers that is anchored around leading providers of value-based care, announced today that it has raised an additional $51 million in funding.
B Capital Group, a leading global technology investor, and Maverick co-led the round.
– Additional existing investors, including Bain Capital Ventures, Company Ventures, Define Ventures, F-Prime Capital, HarbourVest Partners, Ingleside Investors, Nassau Street Ventures, an AVG fund and various individuals also participated.
– These funds will support Centivo’s rapid growth and expansion amid increased demand from employers for health plans that are structurally built to address employee healthcare affordability.

Source
Biotechnology Health Care Life Science Medical North America Software

PhenoTips Closes CAD $2.5M Funding Round Led by GreenSky Capital for Software to Transform Medical Genetics

– PhenoTips announced that it has raised CAD $2.5m in an oversubscribed seed fundraising round led by the GreenSky Accelerator Fund IV.
– The round includes the support of the Toronto Innovation Acceleration Partners, Thin Air Labs, Yorkville Partners, and angel investors including members of the GreenSky President’s Club.
– PhenoTips empowers healthcare providers to deliver precision medicine with the most complete and interoperable software solution for medical genetics.
– The company plans to double the size of its twelve-person Canada-based team and expand its cloud-based product offerings.

Source
Health Care Medical North America Therapeutics

IVX Health Secures $100 Million Growth Investment from Great Hill Partners to Accelerate New Market Expansion

– IVX Health announced the completion of a $100m Series F minority investment from Great Hill Partners.
– Great Hill joins IVX Health’s existing investors including Linden Structured Capital, McKesson Ventures, Health Velocity Capital, and Nueterra Capital.
– IVX Health offers an alternative to hospital-based infusion and injection services, transforming the patient experience by providing a superior level of service in a cost-effective, convenient site of care.
– IVX Health was also named to the prestigious Modern Healthcare Best Places to Work list for a third consecutive year. The organization continues to maintain an industry-leading 97 Net Promoter Score from its patient population.
– Evercore served as financial advisor to IVX Health and TripleTree, LLC served as financial advisor to Great Hill.

Source
Health Care Medical North America Wellness

9am.health launches with $3.7M to tackle virtual diabetes care

– 9am.health, a virtual diabetes clinic, raised $3.7m seed funding.
– The round was led by Founders Fund, Define Ventures, Speedinvest and iSeed Ventures.
– The company plans to target the 1 in 3 people living with diabetes in the United States.

Source
Health Care Medical North America Wellness

Wellthy Announces a Strategic Investment and Partnership With Workday Ventures

– Wellthy received a strategic investment from Workday Ventures and joined the Workday Software Partner Program.
– As a Workday Software Partner, Wellthy plans to build a product integration for shared customers to leverage, which will differentiate their benefit offerings with caregiving support for their employees.
– Wellthy matches families with a dedicated Care Coordinator who manages their care plan, advocates for loved ones, and tackles tasks across medical, in-home, financial, legal, housing, and social and emotional needs.

Source
Biotechnology Health Care Medical Pharmaceutical Therapeutics Wellness Western Europe

Amolyt Pharma Raises $80M in Series B Financing

– Amolyt Pharma from Lyon develops therapeutic peptides for rare endocrine and related diseases.
– The company closed an $80m Series B round.
– The round was co-led by Sectoral Asset Management and Andera Partners, with participation from ATEM Capital, LSP, Novo Holdings (Novo Ventures), Kurma Partners, Mass General Brigham Ventures, Innobio 2 managed by Bpifrance, Orbimed, Pontifax, Eurazeo, Sham Innovation Santé/Turenne Capital and Credit Agricole Creation.
– The company plans to use the proceeds from the financing to advance its pipeline of potential therapeutics for rare endocrine and related diseases, including clinical development of AZP-3601 for hypoparathyroidism, pre-clinical development of AZP-3813 for acromegaly and ongoing research related to AZP-3404, and to further expand its early-stage pipeline through both internal research and development activities and potential in-licensing opportunities.

Source
Biotechnology Health Care Medical Pharmaceutical Therapeutics Wellness Western Europe

Amolyt Pharma Raises $80M in Series B Financing

– Amolyt Pharma from Lyon develops therapeutic peptides for rare endocrine and related diseases.
– The company closed an $80m Series B round.
– The round was co-led by Sectoral Asset Management and Andera Partners, with participation from ATEM Capital, LSP, Novo Holdings (Novo Ventures), Kurma Partners, Mass General Brigham Ventures, Innobio 2 managed by Bpifrance, Orbimed, Pontifax, Eurazeo, Sham Innovation Santé/Turenne Capital and Credit Agricole Creation.
– The company plans to use the proceeds from the financing to advance its pipeline of potential therapeutics for rare endocrine and related diseases, including clinical development of AZP-3601 for hypoparathyroidism, pre-clinical development of AZP-3813 for acromegaly and ongoing research related to AZP-3404, and to further expand its early-stage pipeline through both internal research and development activities and potential in-licensing opportunities.

Source
Analytics Artificial Intelligence Data Visualization Medical North America Software

Caresyntax Grabs $30M Series C Extension

– Caresyntax, the leading enterprise-level digital surgery platform delivering actionable insights to make surgery smarter and safer, today announced a $30m extension to its Series C funding round.
– The round was led by PFM Health Sciences with participation from ProAssurance, Harmonix, and existing investors such as the Relyens Group and IPF Partners.
– That round also included investments from Optum Ventures, Intel Capital, Lauxera Capital Partners, Vesalius Biocapital III, Arno Capital, Rezayat Investments, and Surgical.AI.
– The funding will be used to continue developing its platform as well as advance new data solutions that support value-based care providers.

Source
Medical North America

Francis Medical Raises $55M in Series B Equity Funding

– Francis Medical, a Minneapolis MI-based medical device company, raised $55M in Series B equity funding.
– The round was led by Solas BioVentures with participation from Arboretum Ventures, Coloplast A/S, H2Oey Ventures and Tonkawa.
– The company intends to use the funds to fund for the development of its proprietary prostate cancer treatment through FDA 510(k) approval, which includes a pivotal clinical study (VAPOR 2) for the management of prostate cancer.

Source
Biopharma Biotechnology Health Care Medical North America

Aptinyx Secures $50 Million Growth Capital Credit Facility from K2 HealthVentures

– Aptinyx Inc. has entered into a $50m loan facility and security agreement with K2 HealthVentures.
– The funds will provide general growth capital as Aptinyx advances its late-stage clinical pipeline of novel NMDA modulators.
– Under the terms of the agreement, the remaining $25m is subject to the achievement of certain terms and conditions, including regulatory and developmental milestones.

Source
Biotechnology Health Care Medical North America

Alpine raises $91M to fuel the Seattle biotech’s clinical trials for lupus and cancer

– Alpine Immune Sciences, a publicly traded biotech, raised $91m in funding.
– The funding will support the company’s ongoing trials for cancer and a potential treatment for immune conditions.
– The company plans to initiate a phase 1 study for the agent by this winter.

Source
Biotechnology Medical North America Therapeutics

Allay Therapeutics Completes Oversubscribed $60M Financing to Advance Ultra-Sustained Pain Platform

– Allay Therapeutics completed its oversubscribed $60M Series C financing, led by Arboretum Ventures.
– The proceeds from the Series C will advance the Company’s lead candidate, ATX-101, into Phase 2b clinical trials, and support the further development of Allay’s platform for ultra-sustained analgesic products.
– Allay intends to proceed into a Phase 2b study of ATX-101 in total knee arthroplasties (TKA, also called total knee replacements) in the United States.

Source
Health Care Health Diagnostics Medical North America Therapeutics

Blue Note Therapeutics Raises $5.2M in Additional Series A Funding

– Blue Note Therapeutics raised an additional $5.2m in Series A financing, bringing the company’s Series A financing to a total of $31m.
– The financing was provided by Memorial Sloan Kettering Cancer Center (MSK) and Alumni Ventures who joined Series A lead investors JAZZ Venture Partners and Summer VC.
– The additional proceeds will strengthen Blue Note’s capacity to develop evidence-based therapeutics that serve an increasing number of cancer patients.

Source
Australia and Oceania Biotechnology Health Care Life Science Medical

HaemaLogiX Raises $10M in Funding

– haemaLogiX from Sydney is a biotech company developing a drug to treat a rare blood disorder.
– The company raised $10M in Series A funding.
– The round was led by Platinum Asset Management via its Platinum International Health Care Fund.
– The investment will be used to support the manufacturing of the next batch of the Kappa antibody plus the conduct of a higher dose, 30mg/kg, monotherapy study and prepare for two further studies.

Source
Medical North America Pharmaceutical

CaaMTech Raises $22M in Series A Funding

– CaaMTech is a psychedelic drug discovery company.
– The company raised $22M in Series A funding.
– The round was led by Noetic Fund.
– The new investment will be used to support the company’s cross-disciplinary science program, expand its leadership team, and advance its foremost drug development candidates into human trials.

Source
Biotechnology Health Care Medical North America Pharmaceutical

ADARx Raises $75 Million to Advance Growing Pipeline

– ADARx Pharmaceuticals, Inc. completed a $75m Series B financing.
– The round was co-led by SR One Capital Management and OrbiMed Advisors.
Sirona Capital joined this financing as well as existing investor Lilly Asia Ventures.
– The proceeds from the Series B financing will be used to advance ADARx’s proprietary RNA platform technologies for base editing, inhibition, degradation, and delivery.
– The proceeds will also be used to transition ADARx’s growing pipeline of research phase products into the clinic including initiation of a Phase 1 clinical trial for ADARx’s lead program.

Source
Biotechnology Health Care Life Science Medical North America

Emulate Closes $82 Million Series E Financing to Scale Amid Rapid Growth in Organ-on-a-Chip Market

– Emulate, Inc. announced the close of an $82m Series E financing round.
– The round was led by Northpond Ventures with additional participation from Perceptive Advisors.
– With this investment, Emulate has raised nearly $225m to date.
– Emulate develops and manufactures next-generation in vitro models that enable researchers to replicate and study human biology and disease, helping them understand and predict drug response with greater precision and detail than possible with conventional cell culture or animal-based methods.
– Organ-on-a-chip technology by Emulate provides flexible microenvironments containing tiny hollow channels lined with living cells and tissues that can be subjected to mechanical forces that mirror breathing or digestion in the human body.

Source
Artificial Intelligence Big Data Health Care Health Diagnostics Machine Learning Medical Medical Device Software Software Engineering Western Europe

contextflow Raises €6.7M in Series A Funding

– contextflow from Vienna develops artificial intelligence for medical image analysis.
– A second closing included an additional €2M from new co-investor Peak Pride Management GmbH, HPH (Hans Peter Haselsteiner) Start-up Unit and current investor APEX Ventures with its “APEX Best in Class” fund. A first closing was led by B&C Innovation Investments GmbH (BCII) and included participation from new co-investor TTIP Beteiligungs GmbH and current investors APEX Ventures, Crista Galli Ventures, IST cube, Nina Capital and Novacapital.
– The new investment will be used to accelerate market entry in Europe and the US, including obtaining FDA clearance for contextflow SEARCH Lung CT, as well as extending its offerings to include new products and features covering a wider range of organs and modalities.

Source
Biotechnology Health Care Medical North America

Disc Medicine Raises $90M in Series B Funding

– Disc Medicine from Cambridge MA develops therapeutic candidates for hematology.
– Series B $90M round was led by OrbiMed and attracted new investor – Arix Bioscience as well as existing investors Atlas Venture, Novo Holdings and Access Biotechnology.
– The new investment will be aimed at developing the company’s hematology pipeline of therapeutic candidates.

Source
Biotechnology Health Care Medical North America

HebeCell Raises $53 Million in Series A Financing to Advance Unique Off-The-Shelf PSC-CAR-NK Products Into Clinics

– HebeCell has successfully closed a US$53m Series A financing to advance its unique off-the-shelf pluripotent stem cell (PSC)-CAR-NK products into clinics.
– This strategic investment is led by Jacobio Pharmaceuticals, who will collaborate with HebeCell to develop the next-generation PSC-CAR-NK therapy for cancer, viral infection, and autoimmune diseases.
– Capital from this financing will be used to accelerate HebeCell’s R&D program, IND filing, clinical application, and marketing as the company grows its operations both in the US domestically and internationally. It will also help HebeCell expand globally and gain international presence in the NK cell therapy industry.

Source
Health Care Medical North America Wellness

Alma Pulls In $50M Series C Round

– Alma, a membership-based network for mental health care providers to build and scale their practices, has announced $50m in Series C funding.
– The round is led by global private equity and venture capital firm Insight Partners with participation from Optum Ventures, Tusk Venture Partners, Primary Venture Partners, Sound Ventures, BoxGroup and Rainfall Ventures.
– The company intends to use the funds to fuel Alma’s national expansion and support therapists across the country to offer affordable, in-network care.

Source
Biopharma Health Care Medical North America Pharmaceutical

ARS Pharmaceuticals Raises $55M in Series D Funding

– ARS Pharmaceuticals, a San Diego CA-based pharmaceutical company, raised $55M in Series D funding.
– The round was led by SR One with participation from RA Capital Management and Deerfield Management.
– The company intends to use the funds to advance Neffy through approval, to support initial launch activities, and to evaluate it in clinical studies for additional indications.

Source
Health Care Hospital Medical North America

Wellbe Raises $2M in Series A Funding

– Wellbe Inc. from Madison develops a wellness platform to help consumers and employers manage their healthcare.
– Company raised $2m in Series A funding.
– The round was led by HealthX Ventures with co-investment by WISC Partners.
– The new investment will be aimed at accelerating product innovation and expansion into new markets, continuing focus on client service and platform usability.

Source
Biotechnology Life Science Medical North America Pharmaceutical

Versanis Bio Raises $70M in Series A Financing

– Versanis Bio is an Oakland, Calif.-based company established to discover and develop first-in-class medicines that address medical conditions prevalent in older adults.
– The company closed a $70m Series A financing.
– The round was co-led by Atlas Venture and Medicxi with participation from Aditum Bio.
– The company intends to use the funds to advance a comprehensive phase 2 clinical program to evaluate the potential of bimagrumab to help obese patients lose fat and achieve an improved body composition.

Source
Genetics Health Care Life Science Medical North America

Genome Medical Announces Closing of $60 Million Series C Financing

– Genome Medical, the leading nationwide genomic care delivery company, announced the closing of a $60m Series C financing to accelerate commercial traction and advance its mission of transforming health care for all through genomic medicine.
– These strategic initiatives solidify its position as the preeminent technology-enabled provider of genetic health services and genomic insights.
– Genome Medical will use the financing proceeds to expand its team and further enhance the development of its configurable technology solutions to provide innovative and efficient genomic medicine programs.
– The company will continue to build out its full suite of physician services, test ordering capabilities and guidelines-based care plans to ensure comprehensive, seamless care for patients.

Source
Health Care Health Diagnostics Medical Medical Device North America

Trice Medical Raises Series D Led by Bioventus

– Trice Medical, a Malvern, PA-based imaging technology company, raised a Series D funding.
– The amount of the deal was not disclosed.
– The funding was led by Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing.
– In conjunction with leading the funding, Bioventus will receive exclusive sales and distribution rights to Trice’s products outside of the US.

Source
Artificial Intelligence Health Care Medical North Africa and the Middle East Software

Israel’s DiA gets $14M to expand AI-driven ultrasound analysis

– Israel-based AI healthtech company, DiA Imaging Analysis, which is using deep learning and machine learning to automate analysis of ultrasound scans, has closed a $14m Series B round of funding.
– Backers in the growth round, which comes three years after DiA last raised, include new investors Alchimia Ventures, Downing Ventures, ICON Fund, Philips and XTX Ventures — with existing investors also participating, including CE Ventures, Connecticut Innovations, Defta Partners, Mindset Ventures, and Dr Shmuel Cabilly.
– The latest financing will allow DiA to continue expanding its product range and go after new and expanded partnerships with ultrasound vendors, PACS/Healthcare IT companies, resellers and distributors while continuing to build out its presence across three regional markets.

Source
Biotechnology Health Care Life Science Medical North America

Known Medicine Raises $7.2M in Seed Funding

– Known Medicine is a Salt Lake City, Utah-based 3D cell culture data set company.
– The company raised $7.2M in seed funding.
– The round was led by Caffeinated Capital, with participation from Khosla Ventures, Cota Capital, Kickstart, Forward VC, OATV, Y Combinator, Chris Gibson and Nish Bhat.
– The new investment will be used to grow the company’s proprietary 3D cell culture data set for deployment in partnership with biopharmaceutical companies and in the clinical diagnostics space.

Source
Biotechnology Medical Medical Device North America

DiCE Molecules Announces $60 Million Series C-1 Financing

– DiCE Molecules, a biopharmaceutical company leveraging its proprietary DNA-encoded library platform to discover and develop next-generation therapeutics in immunology and other therapeutic areas, announced the completion of its $60 million Series C-1 financing.
– The financing was led by RA Capital Management and Sands Capital, with participation from new investors Janus Henderson Investors, Deep Track Capital and Logos Capital.
– Existing investors Northpond Ventures, Eventide Asset Management, Driehaus Capital Management, Soleus Capital, New Leaf Venture Partners, Osage University Partners and Asymmetry Capital Management also participated in the round.
– With the closing of this Series C-1 financing round, the Company has raised approximately $200 million to date.

Source
Biotechnology Health Care Medical Neuroscience North America Therapeutics

Xalud Therapeutics Completes Oversubscribed $30 Million Series C Financing

– Xalud Therapeutics announced that it has raised $30m in a Series C financing.
– Xalud is developing novel non-viral gene therapies to treat pathologic inflammation.
– XT-150 is a locally injectable plasmid DNA gene therapy expressing IL-10v – a proprietary long-acting, modified variant of IL-10 with enhanced durability properties over the naturally occurring wild-type cytokine.

Source
Health Care Hospital Medical Medical Device North America Virtual Workforce

SCAN Group Makes Strategic Investment in MedArrive

SCAN Group, whose holdings include SCAN Health Plan, one of the nation’s largest not-for-profit Medicare Advantage plans, has made a strategic investment in MedArrive.
– MedArrive is a healthcare logistics and services platform that enables payers and providers to leverage a network of EMTs, paramedics and other types of skilled healthcare workers to extend care services into the home, improving patient outcomes while empowering an underutilized segment of the healthcare workforce.

Source
Health Care Medical North America

AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research

– AllStripes, a healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, announced the closing of a $50 million Series B financing round.
– The financing was led by Lux Capital, a current investor, joined by JAZZ Venture Partners, Spark Capital, Medidata Solutions (a Dassault Systèmes company), McKesson Ventures, and Maveron, along with angel investors including Arif Nathoo, CEO of Komodo Health, and Leila Zegna, Director of the Kabuki Syndrome Foundation.

Source
Health Care Medical North America

Soda Health Raises $6M in Seed Funding

– Soda Health from Bentonville is a healthcare technology company.
– The company raised $6m in seed funding.
– The round was led by Lightspeed Venture Partners and Define Ventures with participation from Qiming Venture Partners USA.
– The new investment will be used to expand operations and business reach.

Source
Biopharma Biotechnology Health Care Medical Western Europe

SolasCure Raises UK£1.2M in Funding

– SolasCure is a biotech startup that develops wound cleaning products.
– The company raised £1.2m in funding.
Seneca Partners invested in the round.
– The company intends to use the funds for the further development of its wound cleaning product, Aurase®.

Source
Health Care Medical North America Software

bttn. Raises $5M Seed Add-On

– bttn., a Seattle, WA-based healthtech startup, closed a $5M add-on to its seed funding.
– The round was led by Fuse.
– The company intends to use the funds to expand technology, sales, and operations teams to further expand and refine the platform, foster additional partnerships, and extend its customer base.

Source
Health Care Medical North America

Busy pandemic season helps medical supply e-commerce platform Bttn raise $5M

– Seattle-based Bttn. raised $5m funding.
– Bellevue, Wash.-based venture firm FUSE provided the new funding.
– The company plans to expand beyond PPE and has its eye on the wider market.
– Large hospitals spend between $3-20 million on medical supplies each year.

Source
Coworking Electronic Health Record (EHR) Health Care Medical North America Real Estate Software

DocSpace Raises $1.2M in Funding

– DocSpace is a digital health commerce platform for clinicians to start, manage, and grow tech-enabled private practices.
– The company raised $1.2m in seed funding.
– The round was led by Slauson & Co., with participation from Precursor Ventures, Acrew Capital’s Scout Fund, SputnikATX Ventures, and angel investors Nathan Baschez, Sonia Baschez, Nikhil Krishnan, and Eliana Murillo.
– The company intends to use the funds to build out DocSpace Pay, an integrated one-click checkout healthcare payments experience for patients and clinicians.

Source
Health Care Medical Western Europe

EpiEndo Pharmaceuticals Secures EUR 20 Million Series A Funding to Advance Clinical Development of its Non-Antibiotic Macrolide for the treatment of COPD

– EpiEndo Pharmaceuticals announced the closing of a €20m Series A financing round.
– The round was led by Flerie Invest and Iðunn Venture Fund, with existing investors ABC Ventures participating, along with the European Innovation Council joining the round.
– The financing secures funds to advance clinical development of EpiEndo’s lead compound EP395, which entered phase I clinical trials in April, through Phase IIa, targeting COPD as a primary indication.
– EpiEndo’s development rationale is based on a newly acknowledged therapeutic paradigm, that loss of integrity of epithelial barriers plays a critical role in propagating chronic inflammatory diseases in lungs and contributes to vulnerability to infections associated with acute exacerbations of airway diseases.

Source
Artificial Intelligence Computer Vision Health Care Health Diagnostics Medical Software Western Europe

Ultromics Raises $33M in Series B Funding

– Ultromics, an Oxford, UK-based company focused on advancing AI enabled cardiovascular imaging solutions, raised $33M in series B funding.
– The round was led by Blue Venture Fund with participation from Optum Ventures, GV and Oxford Sciences Innovation.
– The new investment will be aimed at accelerating the use of AI-enabled echocardiograms to improve patient care, and bring improved diagnostic quality and resource savings to hospitals.

Source
Medical Medical Device North Africa and the Middle East

Breakthrough Israeli stroke therapy technology BrainQ announces a $40M funding round

– Israeli stroke therapy technology startup, BrainQ, today announced a $40m funding round led by Hanaco Ventures, along with Dexcel Pharma, and Peregrine Ventures.
– The funding will be used to support a multicenter pivotal trial for its groundbreaking technology for ischemic stroke survivors in selected US hospitals.
– This year, BrainQ received FDA Breakthrough Device Designation allowing the company to work closely with the FDA to expedite development plans and premarket clearance, with access to the new Medicare Coverage of Innovative Technology pathway.

Source
Health Care Medical Pharmaceutical Western Europe

Beckley Psytech Closes $80M Series B Funding

– Beckley Psytech an Oxford, England-based private company dedicated to addressing neurological and psychiatric disorders through the novel application of psychedelic medicines closed an $80m Series B financing.
– The round was led by Integrated with participation from Prime Movers Labs, Adage Capital Management, Palo Santo; Delphi VC; Leafy Tunnel; Negev Capital; and existing investor Bicycle Day Ventures.
– The company intends to use the funds to complete the ongoing Phase 1b trial with low-dose psilocybin in patients suffering from SUNHA, a rare and debilitating headache condition estimated to affect 45,000 people in the US and Europe, and to initiate a Phase 1 dose-ranging study on a novel formulation of intranasal 5-MeO-DMT before starting a Phase 2 trial in Treatment Resistant Depression, and expand its pipeline with new, unique and proprietary psychedelic compounds.

Source
Health Care Medical North America Therapeutics

Advanced Chemotherapy Technologies, Inc. Awarded $4 Million NIH Grant to Pursue Treatment for Locally Advanced Non-resectable Pancreatic Cancer

– Advanced Chemotherapy Technologies has been awarded a Phase IIb Small Business Innovation research grant expected to total $4 million over two years from the National Cancer Institute, part of the National Institutes of Health.
– The grant, in combination with prior financing, supports development of the company’s ACT-IOP-003 local drug delivery system for the treatment of locally advanced non-resectable and borderline resectable pancreatic cancer.
– Pancreatic cancer is a devastating disease with 5-year survival rates of only 10%. New treatment modalities are desperately needed and ACT is developing the ACT-IOP-003 system for the targeted delivery of the FDA-approved chemotherapy treatment gemcitabine.

Source
Health Care Medical North America Organic

OrganiCare Raises $8.5M in Series A Funding

– OrganiCare is an Austin TX-based provider of healthcare products.
– Company raised $8.5M in Series A funding.
– Backers include Jake Moilanen, General Partner at Seraph Group.
– The company intends to use the funds to build the FemiClear brand awareness and bring additional product innovation to market.

Source
Health Care Medical Medical Device North America

Fluid Biotech Raises $4.7MUSD in Seed Funding

– Fluid Biotech Inc. from Calgary, AB, Canada closed a $4.7m seed funding round.
– The round was led by Metis Innovative of Miami and ShangBay Capital of Palo Alto, California, with participation from new investors UCeed Health Fund and UCeed Child Health and Wellness Fund from the University of Calgary, Thin Air Labs, Wharton Alumni Angels, Amino Capital, Bluesky Equities, ThresholdImpact and Alabaster Capital.
– The company intends to use the funds to engage contract manufacturers to initiate production, complete regulatory milestones, and plan for first-in-human implantation.

Source
Information Technology Internet Medical North America Therapeutics

Mahana Therapeutics Raises $61M in Series B Financing

– Mahana Therapeutics, a San Francisco, CA-based developer of prescription digital therapeutics designed to empower patients with chronic health conditions, raised $61m in Series B financing.
– The round was led by JAZZ Venture Partners and Gurnet Point Capital with participation from new and existing investors Main Street Advisors, KKCG and Lux Capital.
– The company will use the funds to launch the FDA-cleared prescription digital therapeutic Mahana™ IBS and accelerate development of several digital therapeutics for chronic health conditions.

Source
Eastern Asia Health Care Medical Medical Device

Berry Oncology Closes US$99.15M Series B1 Funding

– Berry Oncology Corporation, a member company of China’s leading early cancer screening firm Berry Genomics, closed a US$99.15m Series B1 financing round.
– This round was led by China Merchants Capital Management Co., Ltd. Existing investors Qiming Venture Partners and Legend Capital, along with new investors including Zhongjin Qichen Industry Equity Investment Fund, E Fund, Fujian Venture Investment Management Co., Ltd., Xiamen C&D Emerging Industry Equity Investment Co., Ltd. and other investors also participated.
– The new proceeds will enable the company to meet the demand for early cancer screening and diagnosis and boost its expansion in the market.

Source
Family Health Care Medical North America Wellness

Juno Medical Raises $5.4M in Seed Funding

– Juno Medical, a New York-based primary care company, raised $5.4m in seed funding.
– The round was led by Vast Ventures with participation from Atento Capital, Company Ventures, humbition, RareBreed Ventures and Lafayette Square.
– The company intends to use the funds to launch its Brooklyn location, expand its virtual care services and price transparency capabilities, and to hire new team members across the business.

Source
Health Care Medical mHealth North America Personal Health Wellness

Humanity launches ‘slow your aging’ app in the UK and raises $2.5M more from health investors

– Humanity, a startup that claims to slow down aging, raised $2.5m in seed funding.
– The round was joined by 65 health-tech and consumer-tech investors.
– The company plans to launch its app in the U.S./worldwide in the first week of September.

Source
Animal Feed Health Care Medical North America Veterinary

Modern Animal Raises $75.5M in Funding

– Modern Animal is a veterinary company based in Los Angeles.
– The company raised $75.5m in funding.
– Over the past year, the company raised: a $35.5M Series A led by True Ventures and Addition and a $40M Series B led by Founders Fund.
– All three firms plus existing investor, Upfront Ventures, participated in both rounds.
– The capital will be used for rapid expansion, as well as continued development of the company’s platform.

Source
Computer Vision Health Care Health Diagnostics Medical North America

Iterative Scopes Raises $30 Million Series A Financing to Advance AI-Driven Precision Medicine for Gastroenterology

– Iterative Scopes closed a $30m Series A financing.
– The round was led by new investor Obvious Ventures, with participation from Eli Lilly, Johnson & Johnson Innovation, the venture capital firms Breyer Capital and Seae Ventures, as well as a number of leaders in healthcare, including Lee Shapiro, Zach Weinberg and Nat Turner.
– The funds will be used to further develop the company’s core algorithmic innovations and to advance its growing life sciences businesses.
– The company is building a powerful set of proprietary artificial intelligence (AI)-driven computational tools to identify appropriate treatments and guide clinical trials for patients suffering from gastrointestinal diseases.

Source
Health Care Medical North America Training

Morgan Health Makes $50 Million Investment in Vera Whole Health

Morgan Health announced an investment in Vera Whole Health, a healthcare company that offers patients coordinated care and an enhanced primary care experience.
– The investment is the first investment in a coordinated care model for Morgan Health.
– Vera is transforming how patients engage with healthcare, how providers deliver care, and how employers pay for care.
– Vera’s model is centered on whole person healthcare led by a team of primary care physicians, nurses and health coaches supported by clinics and an integrated technology platform.
– Vera’s high-touch, advanced primary care model delivers differentiated patient experience, quality outcomes, and cost efficiency for employer and payor partners.
– Employers under contract with Vera have seen an average patient Net Promoter Score of 90, and improved health outcomes and utilization.

Source
Health Care Life Science Medical North America Pharmaceutical

Engrail Therapeutics Extends Series A Financing to $64 Million

– Engrail Therapeutics announced the close of a $32m Series A extension round bringing total investment in the company to $64m.
– The round was led by Nan Fung Life Sciences following their leadership of the original Series A raise.
– The Company will use the proceeds to finance the advancement of its diverse pipeline, including lead assets ENX-101, ENX-102 and internal preclinical programs.
– Engrail’s lead compounds are subtype-selective GABA-A modulators with compelling pharmacological profiles that possess wide ranging therapeutic utility.
– Engrail has assembled a diverse portfolio of assets with validated mechanisms through its dynamic model for advancing drugs aimed at treating life-limiting diseases of the nervous system.

Source
Health Care Medical North America

Bluestone Physician Services Inks Investment

– Bluestone Physician Services from Minnesota has received a strategic investment from the Blue Venture Fund.
– The company provides on-site care and care coordination services to high-risk, geriatric and disabled patients in senior living, community and home-based settings in Minnesota, Wisconsin, Florida, and Virginia.

Source
Biotechnology Health Care Medical North America Therapeutics

Rakuten Medical Closes $166M in Series D Funding

– Rakuten Medical from San Mateo is developing and commercializing innovative oncology products for multiple indications.
– The company raised $166m in Series D funding.
– The round was led by General Catalyst with additional participation from existing investors, including Rakuten Group and SBI Group.
– The new investment will be used to advance ongoing trials of ASP-1929 in several oncologic indications and research and development of additional pipeline therapies being developed using the Illuminox™ platform.

Source
Health Care Medical Medical Device North America

Former Iora Health execs raise $13M to guide seniors through Medicare enrollment

– Connie Health, a Medicare concierge service, raised $13m in Series A funding.
– The round was led by Khosla Ventures and Pitango Healthtech.
– It brings the company to a total of $16m in funding.
– With 55 million Medicare consumers benefiting from major innovation in Medicare Advantage and value-based care, Samir Kaul, founding general partner at Khosla Ventures, saw a large market that was being disrupted by Connie Health.
– The company’s three co-founders, Oded Eran, CEO, David Luna, chief revenue officer, and Michael Scopa, chief growth officer, saw this problem firsthand as executives at primary care company Iora Health, which is being acquired by OneMedical for $2.1 billion.

Source
1 2 3 4
Crunchbase icon

Content report

The following text will be sent to our editors: